ACCEL-LOADING-ACS Study

NCT01354808 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Platelet Aggregation Inhibitors
Anti-inflammatory Agent
Myocardial Reperfusion Injury

Interventions

DRUG: Dual Anti-Platelet Therapy (DAPT)
DRUG: Triple Anti-Platelet Therapy (TAPT)

Sponsor

Gyeongsang National University Hospital